PROMETIC ANNOUNCES POSITIVE LONG TERM CLINICAL DATA ON RYPLAZIM™ IN PLASMINOGEN CONGENITAL DEFICIENCY AND PROVIDES REGULATORY UPDATE

July 11, 2017
Posted by: Fred Dumais
Posted In: Press Releases, Press Releases 2017
X